1. Introduction {#sec1-marinedrugs-17-00061}
===============

Reactive oxygen species (ROS) have unpaired electrons and unstable bonds, which are properties that can lead to cellular damage \[[@B1-marinedrugs-17-00061],[@B2-marinedrugs-17-00061]\] and the regulation transcription factors such as AP-1 and NF-kB \[[@B3-marinedrugs-17-00061],[@B4-marinedrugs-17-00061]\]. Cellular ROS can accumulate in response to exogenous stimuli, including air pollution \[[@B4-marinedrugs-17-00061]\].

The skin is the largest organ in the human body and acts as the first-line defense barrier against harmful stimuli such as ultraviolet (UV) light and air pollution, including particulate matter (PM). Depending on particle size, PM can be classified as ultrafine (particles with a diameter \< 0.1 µm: PM~0.1~), fine (particles with a diameter \< 2.5 µm: PM~2.5~), and coarse (particles with a diameter \< 10 µm: PM~10~) \[[@B5-marinedrugs-17-00061]\]. PM can lead to the development of various skin diseases, including skin aging, alopecia, and skin cancer, through the induction of oxidative stress \[[@B6-marinedrugs-17-00061],[@B7-marinedrugs-17-00061]\]. In addition, PM-induced oxidative stress promoted via the production of ROS and subsequent increase in the activity of matrix metalloproteinases (MMPs) \[[@B6-marinedrugs-17-00061],[@B8-marinedrugs-17-00061]\], including MMP-1, MMP-2, and MMP-9, can cause skin aging as a consequence of the degradation of collagen \[[@B9-marinedrugs-17-00061],[@B10-marinedrugs-17-00061]\].

The generation of ROS has been reported to affect skin aging by increasing the expression of MMP-1 in keratinocytes \[[@B11-marinedrugs-17-00061]\]. Several studies have reported that UVB-induced ROS causes skin photoaging via the promotion of the activity of MMP-1 in human keratinocytes and dermal fibroblasts \[[@B12-marinedrugs-17-00061],[@B13-marinedrugs-17-00061]\], and accordingly, it would be desirable to identify an effective antioxidant that could be used to prevent skin aging.

Oxidative stress is also known to stimulate mitogen-activated protein kinase (MAPK) signaling pathways, which affect the regulation mediated by transcription factor activator protein 1 (AP-1) \[[@B14-marinedrugs-17-00061]\]. Activated (phosphorylated) c-Jun and c-Fos can comprise homodimers or heterodimers that bind to AP-1 binding sites in the promoter region of target genes to promote gene transcription \[[@B15-marinedrugs-17-00061]\] such as that of MMPs \[[@B10-marinedrugs-17-00061]\].

Although previous studies have reported that fermented fish oil (FFO) has an antioxidant and protective effect against UVB-induced oxidative damage \[[@B16-marinedrugs-17-00061]\], the effects of FFO on PM~2.5~-induced skin aging are poorly understood. Therefore, in this study, to gain further insight into the antioxidative properties of FFO we investigated the effects of this oil on PM~2.5~-induced skin aging.

2. Results {#sec2-marinedrugs-17-00061}
==========

2.1. Effect of FFO on PM~2.5~-Induced Intracellular ROS {#sec2dot1-marinedrugs-17-00061}
-------------------------------------------------------

Given that ROS has been reported to affect skin aging via the generation of MMPs \[[@B11-marinedrugs-17-00061]\], we measured the generation of intracellular ROS using 2',7'-dichlorodihydrofluorescein diacetate (DCF-DA) fluorescence dye. The flow cytometry data indicated that PM~2.5~-treated cells induced ROS and that pretreatment with FFO reduced PM~2.5~-induced ROS in HaCaT cells, which was confirmed by confocal microscopy ([Figure 1](#marinedrugs-17-00061-f001){ref-type="fig"}a,b).

2.2. PM~2.5~-Induced Keratinocyte Senescence {#sec2dot2-marinedrugs-17-00061}
--------------------------------------------

Next, we measured β-galactosidase activity, a marker of cellular senescence \[[@B17-marinedrugs-17-00061]\], to detect HaCaT cell senescence using flow cytometry and confocal microscopy after SPiDER-βGal staining. PM~2.5~-treated cells showed increased β-galactosidase activity in the cytosol, whereas FFO treatment was found to decrease the PM~2.5~-induced β-galactosidase activity ([Figure 2](#marinedrugs-17-00061-f002){ref-type="fig"}a,b).

2.3. Effect of FFO on PM~2.5~-Induced MMP-1 Activation and MMP Expression {#sec2dot3-marinedrugs-17-00061}
-------------------------------------------------------------------------

In this study, we examined cellular MMP-1 activity, as MMP-1 is known to be primarily responsible for skin aging via collagen degradation \[[@B18-marinedrugs-17-00061]\]. The treatment of cells with PM~2.5~ significantly increased the activation of MMP-1 after 6, 12, and 24 h ([Figure 3](#marinedrugs-17-00061-f003){ref-type="fig"}a), whereas pretreatment with FFO decreased the PM~2.5~-induced activation of MMP-1 ([Figure 3](#marinedrugs-17-00061-f003){ref-type="fig"}b). The expression of MMP-1 mRNA and protein was also increased in PM~2.5~-treated cells, whereas it was decreased in the cells pretreated with FFO ([Figure 3](#marinedrugs-17-00061-f003){ref-type="fig"}c,d). As MMP-2 and MMP-9 have also been reported to be involved in skin aging through the degradation of collagen \[[@B19-marinedrugs-17-00061]\], we analyzed the expression levels of MMP-2 and MMP-9 protein and found that these were also increased by PM~2.5~ treatment and decreased by FFO pretreatment ([Figure 3](#marinedrugs-17-00061-f003){ref-type="fig"}e).

2.4. Effect of FFO on PM~2.5~-Induced MAPKs and Intracellular Ca^2+^ Levels {#sec2dot4-marinedrugs-17-00061}
---------------------------------------------------------------------------

MAPKs, which enhance the expression of MMP-1, are activated by an increase in the intracellular Ca^2+^ levels \[[@B20-marinedrugs-17-00061]\]. Our western blot analysis indicated that PM~2.5~ treatment induced the activation (phosphorylation) of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK), whereas this activation was decreased following FFO pretreatment. Furthermore, PM~2.5~ treatment induced the activation (phosphorylation) of MAPK kinase (MEK) 1/2 and SAPK/ERK kinase (SEK) 1 ([Figure 4](#marinedrugs-17-00061-f004){ref-type="fig"}a), and significantly increased the levels of intracellular Ca^2+^, whereas FFO decreased the PM~2.5~-induced increase in Ca^2+^ levels ([Figure 4](#marinedrugs-17-00061-f004){ref-type="fig"}b,c).

2.5. Effect of FFO on PM~2.5~-Induced Transcription Factor Activator Protein 1 (AP-1) Expression {#sec2dot5-marinedrugs-17-00061}
------------------------------------------------------------------------------------------------

The nuclear transcription factor, AP-1, regulated by MAPKs, increases the expression of MMPs \[[@B12-marinedrugs-17-00061],[@B21-marinedrugs-17-00061]\]. The activation of MAPKs results in the heterodimerization of c-Jun/c-Fos and the formation of an AP-1 complex \[[@B10-marinedrugs-17-00061]\]. As shown in [Figure 4](#marinedrugs-17-00061-f004){ref-type="fig"}, PM~2.5~ treatment increased MAPK activity and intracellular Ca^2+^ levels. Western blot analysis of c-Fos and phospho-c-Jun levels indicated that FFO significantly decreased the PM~2.5~-induced increase in phospho-c-Jun and c-Fos levels ([Figure 5](#marinedrugs-17-00061-f005){ref-type="fig"}a). In addition, FFO reduced the PM~2.5~-induced AP-1 binding to the MMP-1 promoter ([Figure 5](#marinedrugs-17-00061-f005){ref-type="fig"}b).

3. Discussion {#sec3-marinedrugs-17-00061}
=============

The skin is the largest organ in the human body and acts as a first-line defense barrier against harmful environmental stimuli, including PM. In several studies, PM~2.5~ has been reported to have harmful effects associated with inflammatory skin diseases, skin aging, and damage to the respiratory system through the generation of intracellular ROS \[[@B6-marinedrugs-17-00061],[@B22-marinedrugs-17-00061],[@B23-marinedrugs-17-00061]\]. The accumulation of ROS has been reported to induce skin aging through the expression of MMPs, including MMP-1, MMP-2, and MMP-9 \[[@B24-marinedrugs-17-00061]\]. Accordingly, it is desirable to identify an effective antioxidant that could be used to prevent skin aging.

Previous studies have demonstrated that mackerel-derived FFO has a direct ROS scavenging effect and a protective effect against UVB-induced oxidative damage \[[@B16-marinedrugs-17-00061]\]. In the present study, we focused on the effect of mackerel-derived FFO against PM~2.5~-induced skin aging.

We initially measured the generation of intracellular ROS induced by PM~2.5~ treatment, and accordingly found that pretreatment with FFO significantly reduced the induction of intracellular ROS by PM~2.5~ treatment ([Figure 1](#marinedrugs-17-00061-f001){ref-type="fig"}a,b). Given that the generation of ROS causes skin aging, we investigated keratinocyte senescence by examining the activity of the marker enzyme β-galactosidase \[[@B25-marinedrugs-17-00061]\]. We found that PM~2.5~ treatment increased β-galactosidase activity, whereas FFO pretreatment significantly reduced the PM~2.5~-induced β-galactosidase activity ([Figure 2](#marinedrugs-17-00061-f002){ref-type="fig"}a,b). As MMPs are known to cause skin aging through the degradation of collagen \[[@B9-marinedrugs-17-00061],[@B10-marinedrugs-17-00061]\], we also examined the activity of MMP-1 and the expression levels of MMP-1, MMP-2, and MMP-9. Again, we found that FFO has an inhibitory effect on PM~2.5~-induced MMPs ([Figure 3](#marinedrugs-17-00061-f003){ref-type="fig"}). These results indicate that PM~2.5~ induces skin aging by promoting the expression of MMPs, whereas FFO has anti-aging effects via its ROS scavenging activity.

ROS activated MAPK signaling pathways, and the activation of MAPKs, in turn, induced various transcription factors, including AP-1 and NF-κB \[[@B14-marinedrugs-17-00061],[@B26-marinedrugs-17-00061]\]. As a result of the translocation of activated AP-1, heterodimers comprising c-Jun and c-Fos and MMPs were synthesized \[[@B27-marinedrugs-17-00061],[@B28-marinedrugs-17-00061]\]. As shown in [Figure 4](#marinedrugs-17-00061-f004){ref-type="fig"}a, ERK and JNK were activated by PM~2.5~ treatment, and this activation was reduced by FFO pretreatment. The activation of MEK and SEK, upstream of ERK and JNK, respectively, was also increased by PM~2.5~ treatment, and this increase was again decreased by FFO pretreatment ([Figure 4](#marinedrugs-17-00061-f004){ref-type="fig"}a). In addition, intracellular Ca^2+^ levels, which regulate MAPKs, were significantly increased in PM~2.5~-treated cells, whereas pretreatment with FFO was found to decrease the observed PM~2.5~-induced increase in Ca^2+^ levels ([Figure 4](#marinedrugs-17-00061-f004){ref-type="fig"}b,c). Furthermore, phospho-c-Jun and c-Fos levels were increased in PM~2.5~-treated cells and decreased in cells receiving pretreatment with FFO ([Figure 5](#marinedrugs-17-00061-f005){ref-type="fig"}a). We also found that PM~2.5~-induced AP-1 binding to the MMP-1 promoter was reduced by FFO pretreatment ([Figure 5](#marinedrugs-17-00061-f005){ref-type="fig"}b). These results therefore provide evidence that FFO can block the activation of the MAPK/AP-1 pathway induced by PM~2.5~ in human keratinocytes. FFO showed an antioxidant effect in this study and in our previous study \[[@B16-marinedrugs-17-00061]\]. However, we did not assess whether FFO may induce the nuclear factor-erythroid 2-related factor 2-mediated antioxidant enzyme pathway to scavenge ROS. This will be evaluated in a future study.

In conclusion, mackerel-derived FFO has anti-aging effects against PM~2.5~-induced skin aging through a reduction in the generation of intracellular ROS and expression of MMPs ([Figure 5](#marinedrugs-17-00061-f005){ref-type="fig"}c).

4. Materials and Methods {#sec4-marinedrugs-17-00061}
========================

4.1. Cell Culture and Treatment {#sec4dot1-marinedrugs-17-00061}
-------------------------------

HaCaT human keratinocytes (CLS Cell Lines Service GmbH, Eppelheim, Germany) were cultured in DMEM medium (Gibco, Life Technologies Co., Grand Island, NY, USA) supplemented with 10% fetal bovine serum and antibiotics (100 units/mL penicillin, 100 µg/mL streptomycin, and 0.25 µg/mL amphotericin B) (Gibco, Life Technologies Co., Grand Island, NY, USA) at 37 °C in an incubator with a humidified atmosphere of 5% CO~2~. Cells were treated with 50 μg/mL diesel particulate matter NIST 1650b (PM~2.5~) (Sigma-Aldrich Chemical Company, St. Louis, MO, USA) and 20 μg/mL FFO. The preparation of PM~2.5~ and FFO has been described in previous studies \[[@B16-marinedrugs-17-00061],[@B29-marinedrugs-17-00061]\].

4.2. Detection of Intracellular ROS {#sec4dot2-marinedrugs-17-00061}
-----------------------------------

For the detection of intracellular ROS in HaCaT cells, the cells were seeded in 6-well culture plates at a density of 1.0 × 10^5^ cells/well, cultured for 16 h, and treated with 20 μg/mL FFO and 50 μg/mL PM~2.5~. After 30 min, 50 μM 2',7'-dichlorodihydrofluorescein diacetate (DCF-DA, Molecular Proves, Eugene, OR, USA) solution was added to the cells. After 15 min incubation at 37 °C, DCF fluorescence was measured using a BD LSRFortessa flow cytometer (PerkinElmer, Waltham, MA, USA). For imaging, cells were seeded in a 4-well glass chamber slide at a density of 1.0 × 10^5^ cells/well, cultured for 16 h, and treated with 20 μg/mL FFO and 50 μg/mL PM~2.5~. After 30 min, 50 μM DCF-DA (Molecular Proves, Eugen, OR, USA) solution was added to the cells. After 15 min incubation at 37 °C, the cells were washed 3 times with PBS. DCF fluorescence images were obtained using a FV1200 laser scanning confocal microscope (Olympus, Tokyo, Japan).

4.3. Detection of β-Galactosidase Activity {#sec4dot3-marinedrugs-17-00061}
------------------------------------------

β-galactosidase activity is a classic marker of cellular aging \[[@B30-marinedrugs-17-00061]\], and we accordingly measured the activity of this enzyme to detect cell senescence. Cells were seeded in 6-well culture plates at a density of 1.0 × 10^5^ cells/mL, and after a 16-h incubation at 37 °C, they were treated with 20 μg/mL FFO and 50 μg/mL of PM~2.5~, followed by the addition of 2 μM SPiDER-βGal solution (Dojindo Molecular Technologies, Inc., Rockville, MD, USA) 24 h later. After a 15-min incubation at 37 °C, SPiDER-βGal fluorescence was measured using a BD LSRFortessa flow cytometer (PerkinElmer, Waltham, MA, USA). For imaging, cells were seeded in a 4-well glass chamber slide at a density of 1.0 × 10^5^ cells/well, and after a 16 h incubation at 37 °C, they were treated with 20 μg/mL FFO and 50 μg/mL of PM~2.5~, followed by the addition of 2 μM SPiDER-βGal solution (Dojindo Molecular Technologies, Inc., Rockville, MD, USA) 24 h later. After a 15 min incubation at 37 °C, the cells were washed 3 times with PBS. After washing, the cells were treated with mounting medium containing DAPI to label nuclei. SPiDER-βGal fluorescence images were obtained using an FV1200 laser scanning confocal microscope (Olympus, Tokyo, Japan).

4.4. MMP-1 Activity {#sec4dot4-marinedrugs-17-00061}
-------------------

MMP-1 activity was measured using a Fluorokine^®^ E human active MMP-1 fluorescent assay kit (R&D Systems Inc., Minneapolis, MN, USA). HaCaT cells were seeded in a 60 mm culture dish at 1.0 × 10^5^ cells/mL. After a 16 h incubation at 37 °C, the cells were treated with 20 μg/mL FFO, and 1 h thereafter with 50 μg/mL PM~2.5~. MMP-1 activity was assessed according to the manufacturer's instructions. Fluorescence was measured using a Spectra Max i3x microplate reader (Molecular Devices, San Jose, CA, USA).

4.5. Reverse Transcription--PCR (RT-PCR) {#sec4dot5-marinedrugs-17-00061}
----------------------------------------

Cells were seeded in a 60 mm culture dish at 1.5 × 10^5^ cells/mL, and after a 1 h incubation at 37 °C, cells were treated with 20 μg/mL FFO and 50 μg/mL PM~2.5~. After 24 h, we isolated total RNA from cells using an easy-BLUE™ total RNA extraction kit (iNtRON Biotechnology Inc., Seongnamsi, Korea). Subsequently, cDNA was amplified using reverse transcription reaction buffer, primers, dNTPs, and Taq DNA polymerase in a final volume of 20 μL. The amplified products were mixed with 6× blue/orange loading dye and resolved by electrophoresis on 1% agarose gels. Gels were subsequently stained with RedSafe™ nucleic acid staining solution (iNtRON Biotechnology Inc., Seongnamsi, Korea), photographed under a UV light, and analyzed using Image Quant™ TL analysis software (Amersham Biosciences, Uppsala, Sweden). The PCR conditions used were as follows: an initial denaturation at 94 °C for 5 min, followed by 30 cycles of 94 °C for 30 s, 55 °C for 30 s, and 72 °C for 1 min. The primers used in this study were as follows: human MMP-1: forward (5'-GGAGGAAATCTTGCTCAT-3') and reverse (5'-CTCAGAAAGAGCAGCATC-3'); human GAPDH: forward (5′-TCAAGTGGGGCGATGCTGGC-3') and reverse (5′-TGCCAGCCCCAGCGTCAAAG-3').

4.6. Western Blot Analysis {#sec4dot6-marinedrugs-17-00061}
--------------------------

Protein lysates (30 μg per lane) were electrophoresed on 12% SDS-polyacrylamide gels, and then transferred to nitrocellulose membranes, which were incubated with the primary antibodies and subsequently with HRP-conjugated secondary antibodies (Invitrogen, Carlsbad, CA, USA). Thereafter, the membranes were developed using a western blotting detection kit (GE Healthcare Life Sciences, Buckinghamshire, Little Chalfont, UK) for detection of the protein bands and then exposed to X-ray film. The primary antibodies used in this study were as follows: MMP-1 (Cusabio Technology LLC., Houston, TX, USA), MMP-2 (Abcam, Cambridge, UK), MMP-9 (Abcam, Cambridge, UK), phospho-c-Jun (Cell Signaling Technology, Danvers, MA, USA), c-Fos (Cell Signaling Technology, Danvers, MA, USA), phospho-SEK (Cell Signaling Technology, Danvers, MA, USA), phospho-MEK (Cell signaling Technology, Danvers, MA, USA), phospho-ERK (Santa Cruz Biotechnology, Santa Cruz, CA, USA), phospho-JNK (Cell Signaling Technology, Danvers, MA, USA), and Actin (Sigma-Aldrich Chemical Company, St. Louis, MO, USA).

4.7. Measurement of Ca^2+^ Levels {#sec4dot7-marinedrugs-17-00061}
---------------------------------

To determine cellular Ca^2+^ levels, cells were seeded in 6-well culture plates at a density of 1.0 × 10^5^ cells/well, cultured for 16 h, and then treated with 20 μg/mL FFO and 50 μg/mL PM~2.5~. After 24 h, 5 μM Fluo-4-AM (Molecular Probes, Eugene, OR, USA) solution was added to the cells. After 15 min incubation at 37 °C, Fluo-4-AM fluorescence was measured using a BD LSRFortessa flow cytometer (PerkinElmer, Waltham, MA, USA). For imaging, cells were seeded in a 4-well glass chamber slide at a density of 1.0 × 10^5^ cells/well, cultured for 16 h, and then treated with 20 μg/mL FFO and 50 μg/mL PM~2.5~. After 24 h, 5 μM Fluo-4-AM (Molecular Probes, Eugen, OR, USA) solution was added to the cells. After a 15 min incubation at 37 °C, the cells were washed 3 times with PBS. After washing, Flou-4-AM fluorescence images were obtained using an FV1200 laser scanning confocal microscope (Olympus, Tokyo, Japan).

4.8. Chromatin Immunoprecipitation (ChIP) Assay {#sec4dot8-marinedrugs-17-00061}
-----------------------------------------------

ChIP assays were performed using a SimpleChIP™ enzymatic chromatin IP kit (Cell Signaling Technology, Danvers, MA, USA). HaCaT cells were seeded in a 100 mm culture dish at 1.5 × 10^5^ cells/mL, and after 16 h, were treated with 20 μg/mL FFO and 50 μg/mL PM~2.5~. All processes were performed according to the manufacturer's instructions. As an antibody, we used a c-Jun antibody (Invitrogen, Carlsbad, CA, USA). The following primers were designed from the MMP-1 gene promoter (−67 to +94 of the MMP-1 gene sequence from the transcription starting site; Bionics): sense 5′-CCTCTTGCTGCTCCAATATC-3′ and antisense 5′-TCTGCTAGGAGTCACCATTTC-3′. PCR products were separated on 1% agarose gels. DNA bands were photographed under a UV light and were analyzed using Image Quant™ TL analysis software version 1.0.2 (Amersham Biosciences, Uppsala, Sweden).

4.9. Statistical Analysis {#sec4dot9-marinedrugs-17-00061}
-------------------------

All analyses were performed in triplicate and all values are expressed as the mean ± standard error of the means. The results were assessed using one-way analysis of variance with Tukey's test using the SigmaStat version 3.5 software (Systat Software Inc., San Jose, CA, USA) to determine the statistical significance of differences between means. A *p*-value \< 0.05 was considered to be statistically significant.
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![Scavenging effect of fermented fish oil (FFO) on PM~2.5~-induced intracellular reactive oxygen species (ROS). Intracellular ROS were detected by (**a**) flow cytometry and (**b**) confocal microscopy after DCF-DA staining. \* *p* \< 0.05 and \# *p* \< 0.05 compared with untreated cells and PM~2.5~-treated cells, respectively.](marinedrugs-17-00061-g001){#marinedrugs-17-00061-f001}

![PM~2.5~-induced keratinocyte senescence. (**a**) β-galactosidase activity was measured by flow cytometry and (**b**) confocal microscopy after SPiDER-βGal staining. \* *p* \< 0.05 and \# *p* \< 0.05 compared with untreated cells and PM~2.5~-treated cells, respectively.](marinedrugs-17-00061-g002){#marinedrugs-17-00061-f002}

![Effect of fermented fish oil (FFO) on PM~2.5~-induced MMP-1 activation and matrix metalloproteinase (MMP) expression. (**a**) The MMP-1 activity of PM~2.5~-treated cells at the indicated times and (**b**) the MMP-1 activity of FFO and PM~2.5~ treated cells were determined using a human active MMP-1 fluorescent assay kit. \* *p* \< 0.05 and \# *p* \< 0.05 compared with untreated cells and PM~2.5~-treated cells, respectively. (**c**) Expression level of MMP-1 was analyzed by western blot analysis. Actin was used as a loading control. \* *p* \< 0.05 compared with untreated cells. (**d**) The mRNA and protein levels of MMP-1 were analyzed by RT-PCR and western blotting, respectively. GAPDH and actin were used as loading controls. \* *p* \< 0.05 and \# *p* \< 0.05 compared with untreated cells and PM~2.5~-treated cells, respectively. (**e**) Expression level of MMP-2 and MMP-9 were analyzed by western blotting. Actin was used as a loading control. \* *p* \< 0.05 and \# *p* \< 0.05 compared with untreated cells and PM~2.5~-treated cells, respectively.](marinedrugs-17-00061-g003){#marinedrugs-17-00061-f003}

![Effect of fermented fish oil (FFO) on PM~2.5~-induced MAPKs and intracellular Ca^2+^ level. (**a**) Expression level of phospho-MEK, phospho-ERK, phospho-SEK, and phospho-JNK determined by western blot analysis. Actin was used as a loading control. \* *p* \< 0.05 and \# *p* \< 0.05 compared with untreated cells and PM~2.5~-treated cells, respectively. (**b**) Intracellular Ca^2+^ level was detected by flow cytometry and (**c**) confocal microscopy after Flou-4-AM staining. \* *p* \< 0.05 and \# *p* \< 0.05 compared with untreated cells and PM~2.5~-treated cells, respectively.](marinedrugs-17-00061-g004){#marinedrugs-17-00061-f004}

![Effect of fermented fish oil (FFO) on PM~2.5~-induced transcription factor activator protein 1 (AP-1) expression. (**a**) Expression level of phospho-c-Jun and c-Fos determined by western blot analysis. Actin was used as a loading control. \* *p* \< 0.05 and \# *p* \< 0.05 compared with untreated cells and PM~2.5~-treated cells, respectively. (**b**) AP-1 binding to the MMP-1 promoter was assessed by ChIP assay. \* *p* \< 0.05 and \# *p* \< 0.05 compared with untreated cells and PM~2.5~-treated cells, respectively. (**c**) Schematic diagram of the effect of FFO on PM~2.5~-induced skin aging. Exposure to PM~2.5~ increased intracellular reactive oxygen species (ROS) and induced skin aging in HaCaT cells. The mackerel-derived FFO had an anti-aging effect on PM~2.5~-induced skin aging through reduced intracellular ROS.](marinedrugs-17-00061-g005){#marinedrugs-17-00061-f005}
